1. Home
  2. SU vs INSM Comparison

SU vs INSM Comparison

Compare SU & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Suncor Energy  Inc.

SU

Suncor Energy Inc.

HOLD

Current Price

$44.28

Market Cap

50.5B

Sector

Energy

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$191.91

Market Cap

41.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SU
INSM
Founded
1917
1988
Country
Canada
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.5B
41.2B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
SU
INSM
Price
$44.28
$191.91
Analyst Decision
Buy
Strong Buy
Analyst Count
1
19
Target Price
$65.00
$178.71
AVG Volume (30 Days)
4.3M
2.7M
Earning Date
11-04-2025
10-30-2025
Dividend Yield
3.74%
N/A
EPS Growth
N/A
N/A
EPS
3.06
N/A
Revenue
$35,463,676,235.00
$447,022,000.00
Revenue This Year
$0.64
$43.10
Revenue Next Year
N/A
$128.25
P/E Ratio
$14.42
N/A
Revenue Growth
N/A
30.34
52 Week Low
$30.79
$60.40
52 Week High
$45.60
$212.75

Technical Indicators

Market Signals
Indicator
SU
INSM
Relative Strength Index (RSI) 56.28 44.31
Support Level $43.74 $202.68
Resistance Level $45.48 $206.69
Average True Range (ATR) 0.80 6.67
MACD -0.21 -3.09
Stochastic Oscillator 30.60 0.91

Price Performance

Historical Comparison
SU
INSM

About SU Suncor Energy Inc.

Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil production, petroleum refining in Canada and the U.S., and the company's Petro-Canada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, and renewable fuels. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power. The company's operating segments include Oil Sands, Exploration & Production, Refining & Marketing (R&M), and Corporate & eliminations. Geographically, the company generates a majority of its revenue from Canada.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: